Abstract:Loss-of-function mutations in the cardiac Na+ channel α-subunit Nav1.5, encoded by SCN5A, cause Brugada syndrome (BrS), a hereditary disease characterized by sudden cardiac death due to ventricular fibrillation. We previously evidenced in vitro the dominant-negative effect of the BrS Nav1.5-R104W variant, inducing retention of wild-type (WT) channels and leading to a drastic reduction of the resulting Na+ current (I Na ). To explore this dominant-negative effect in vivo, we created a murine model using adeno-associated viruses (AAVs). Methods: Due to the large size of SCN5A, a dual AAV vector strategy was used combining viral DNA recombination and trans-splicing. Mice were injected with two AAV serotypes capsid 9: one packaging the cardiac specific troponin-T promoter, the 5' half of hSCN5A cDNA, a splicing donor site and a recombinogenic sequence; and another packaging the complementary recombinogenic sequence, a splicing acceptor site, the 3' half of hSCN5A cDNA fused to the gfp gene sequence, and the SV40 polyA signal. Eight weeks after AAV systemic injection in wild-type (WT) mice, echocardiography and ECG were recorded and mice were sacrificed. The full-length hSCN5A-gfp expression was assessed by western blot and immunohistochemistry in transduced heart tissues and the Na+ current was recorded by the patch-clamp technique in isolated adult GFP-expressing heart cells. Results: Almost 75% of the cardiomyocytes were transduced in hearts of mice injected with hNav1.5 and ∼30% in hNav1.5-R104W overexpressing tissues. In ventricular mice cardiomyocytes expressing R104W mutant channels, the endogenous I Na was significantly decreased. Moreover, overexpression of R104W channels in normal hearts led to a decrease of total Nav1.5 expression. The R104W mutant also induced a slight dilatation of mice left ventricles and a prolongation of RR interval and P-wave duration in transduced mice. Altogether, our results demonstrated an in vivo dominant-negative effect of defective R104W channels on endogenous ones. Conclusion: Using a trans-splicing and viral DNA recombination strategy to overexpress the Na+ channel in mouse hearts allowed us to demonstrate in vivo the dominant-negative effect of a BrS variant identified in the N-terminus of Nav1.5.

Variable Penetrance and Expressivity of a Rare Pore Loss-of-Function Mutation (p.L889V) of Nav1.5 Channels in Three Spanish Families

Variable epilepsy phenotypes associated with heterozygous mutation in the SCN9A gene: report of two cases

Loss of sodium current caused by a Brugada syndrome-associated variant is determined by patient-specific genetic background

Functional Characteristics of the Nav1.1 p.Arg1596Cys Mutation Associated with Varying Severity of Epilepsy Phenotypes

Compound Heterozygous Mutations P336L and I1660V in the Human Cardiac Sodium Channel Associated with the Brugada Syndrome.

The Biallelic Inheritance of Two Novel SCN1A Variants Results in Developmental and Epileptic Encephalopathy Responsive to Levetiracetam

A Novel Functional Variant Residing Outside the SCN5A-encoded Nav1.5 Voltage-Sensing Domain Causes Multifocal Ectopic Purkinje-related Premature Contractions

Clinical heterogeneity in sodium channelopathies. What is the meaning of carrying a genetic mutation?

p.D1690N sodium voltage-gated channel α subunit 5 mutation reduced sodium current density and is associated with Brugada syndrome.

A Novel Cardiac Nav1.5 Channel Mutation, L812Q, Leads to Brugada Syndrome

In vivo Dominant-Negative Effect of an SCN5A Brugada Syndrome Variant

Clinical Heterogeneity in Sodium Channelopathies

De Novo Mutation in the SCN5A Gene Associated with Brugada Syndrome.

A Common SCN5A Polymorphism Attenuates a Severe Cardiac Phenotype Caused by a Nonsense SCN5A Mutation in a Chinese Family with an Inherited Cardiac Conduction Defect

A Missense Mutation in the Sodium Channel β2 Subunit Reveals SCN2B as a New Candidate Gene for Brugada Syndrome

Electrophysiological Characteristics Of A Scn5a Voltage Sensors Mutation R1629q Associated With Brugada Syndrome

A Study among the Genotype, Functional Alternations, and Phenotype of 9 SCN1A Mutations in Epilepsy Patients

Novel SCN9A Missense Mutations Contribute to Congenital Insensitivity to Pain: Unexpected Correlation Between Electrophysiological Characterization and Clinical Phenotype

Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutations

The SCN1A Mutation Database: Updating Information and Analysis of the Relationships among Genotype, Functional Alteration, and Phenotype

Clinical Comparison and Functional Study of the L703P: a Recurrent Mutation in Human SCN4A That Causes Sodium Channel Myotonia.